Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Significant customer win

19 Dec 2016 07:01

RNS Number : 1620S
WANdisco Plc
19 December 2016
 

For immediate release

19 December 2016

 

WANdisco plc

("WANdisco" or the "Company")

 

Significant customer win

 

WANdisco Fusion secures major new customer through IBM partnership

 

WANdisco (LSE: WAND), the leading provider of continuous availability software for global enterprises to meet the challenges of Big Data, is pleased to announce that through its OEM sales partnership with IBM, the Company has secured a significant contract win with a major automotive multinational. The agreement will see IBM deploy the Company's patented cloud solution, WANdisco Fusion, rebranded as IBM Big Replicate, direct to the customer. The agreement is valued at approximately $1m in royalties to be paid to WANdisco.

 

WANdisco Fusion, will be used to ensure customer data is moved seamlessly between data centers and the cloud. It is imperative this is done without any downtime or disruption, and WANdisco Fusion is the only solution capable of delivering this with continuously changing large data sets as the customer moves to self-driving cars, following a major trend transforming the automotive industry.

 

This deal follows a smaller order with a major European bank that IBM closed on behalf of WANdisco through the OEM sales partnership in Q3 this year, after finalising the OEM deal in April 2016. In addition, WANdisco has now completed joint product development and has trained over 5,000 quota carrying IBM reps, demonstrating the true scale of this partnership.

 

David Richards, Chief Executive Officer and Interim Chairman of WANdisco, commented:

 

"This is an extremely important contract win for WANdisco which demonstrates our OEM partnership with IBM is capable of delivering significant value for our business. This agreement has been secured on the basis that WANdisco Fusion was the only solution that could ensure complete data consistency without any downtime - which continues to distinguish us from our competitors.

 

"Both WANdisco and IBM continue to develop a significant pipeline of new business opportunities."

 

 

For further information, please contact:

 

WANdisco plc

via Vigo Communications

David Richards, Chief Executive Officer and Interim Chairman

 

Erik Miller, Chief Financial Officer

 

Vigo Communications

+44 (0)207 830 9700

Jeremy Garcia / Fiona Henson / Antonia Pollock

www.vigocomms.com

Stifel (Joint Broker and Nomad)

+44 (0)207 710 7600

David Arch / Fred Walsh / Neil Shah

 

 

 

UBS (Joint Broker)

Rahul Luthra / Sandip Dhillon

+44 (0)207 567 8000

 

About WANdisco

WANdisco (LSE: WAND) is the world leader in Active Transactional Data Replication™. Its patented technology provides continuous consistent access to changing data anytime and anywhere with no downtime and no disruption. WANdisco's patented technology serves crucial high availability (HA) requirements, including migration to cloud, Hadoop Big Data and Application Lifecycle Management (ALM), Subversion, Git and Gerrit.

 

WANdisco works directly with Fortune 1000 companies around the world and in all sectors to ensure their data, whether it is on-premise or in the cloud, gives them the real insight they need. WANdisco has an OEM with IBM and is also partnered with Amazon Web Services, Cisco, Google Cloud Platform, Hewlett Packard Enterprise, Microsoft Azure and Oracle to resell its patented technology. WANdisco is committed to the ODPi Interoperable Compliance Program to ensure its products are interoperable across a wider range of commercial Apache™ Hadoop® Platforms.

 

For additional information, please visit www.wandisco.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTBRBDDBXBBGLL
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.